abstract |
The present invention provides mammalian cells capable of producing recombinant CTLA4-Ig and variants thereof. The invention also provides compositions and formulations thereof comprising CTLA4-Ig. The present invention further provides a method for mass-producing CTLA4-Ig and a method for purifying CTLA4-Ig from mammalian cells capable of producing said recombinant protein. |